EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
Cited by 68
Related Papers
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
|Choice Reviews Online|2008|5.4k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
|Neoplasia|2000|212
miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
|Journal of Experimental & Clinical Cancer Research|2018|92